Relypsa to Present at 36th Annual Cowen Health Care Conference

REDWOOD CITY, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq: RLYP) today announced that John A. Orwin, president and chief executive officer, will present at the 36th Annual Cowen Health Care Conference on March 8, 2016 at 8:00 a.m. ET.

To access the live webcasts and subsequent archived recordings of these presentations, please visit Relypsa's website at http://investor.relypsa.com/events.cfm.

About Relypsa, Inc.

Relypsa, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of polymeric medicines for patients with conditions that are often overlooked and undertreated and can be addressed in the gastrointestinal tract. The Company’s first medicine, Veltassa® (patiromer) for oral suspension, was developed based on Relypsa’s rich legacy in polymer science. Veltassa is approved in the United States for the treatment of hyperkalemia. Veltassa has intellectual property protection until 2030 in the United States and 2029 in the European Union. More information is available at www.relypsa.com.

Contact:Alex DobbinAssociate Director, Investor Relations650-421-9687[email protected]

You May Also Be Interested In

• TD Cowen Upgrades DaVita (DVA) to Buy
• Nathan's Famous, Inc. Reports First Quarter Results
• TD Cowen Starts Obsidian Therapeutics (OBX) at Buy